Arkolith/Insider Trading/LXEO/Form 4/A

Otero Jose Manuel

Chief Operating OfficerLexeo Therapeutics, Inc. (LXEO) · full profile →Form 4/A · filed Feb 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$7K
Net Open-Market Flow
-$7K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2025Sell(S)721$9.27$7K63K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0002024096-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML